Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors.

Arch Dermatol Res

Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, 833 Chestnut Street, Philadelphia, PA, 19107, USA.

Published: November 2024

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00403-024-03542-8DOI Listing

Publication Analysis

Top Keywords

risk estrogen-driven
4
estrogen-driven malignancies
4
malignancies females
4
females 5-alpha
4
5-alpha reductase
4
reductase inhibitors
4
risk
1
malignancies
1
females
1
5-alpha
1

Similar Publications

Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors.

Arch Dermatol Res

November 2024

Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, 833 Chestnut Street, Philadelphia, PA, 19107, USA.

View Article and Find Full Text PDF

Thrombotic complications in pregnancy: a case-based review of the evidence.

J Thromb Haemost

October 2024

Division of Hematology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Pregnancy is a prothrombotic state due to an estrogen-driven shift in the coagulation system, increased venous stasis, and external restriction of blood flow caused by the gravid uterus. Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in pregnancy. Preventing, recognizing, and treating thrombosis in pregnancy, as well as the postpartum period, often challenges decision making in the clinical setting.

View Article and Find Full Text PDF

Estrogen Receptor 1 (ESR1; also known as ERα, encoded by gene) is the main driver and prime drug target in luminal breast cancer. ESR1 chromatin binding is extensively studied in cell lines and a limited number of human tumors, using consensi of peaks shared among samples. However, little is known about inter-tumor heterogeneity of ESR1 chromatin action, along with its biological implications.

View Article and Find Full Text PDF

Estrogen Receptor alpha (ERα) is the main driver and prime drug target in luminal breast. ERα chromatin binding is extensively studied in cell lines and a limited number of human tumors, using consensi of peaks shared among samples. However, little is known about inter-tumor heterogeneity of ERα chromatin action, along with its biological implications.

View Article and Find Full Text PDF

In female mammals, the development and regulation of the reproductive system and non-reproductive system are significantly influenced by estrogens (oestrogens). In addition, lipid metabolism is another physiological role of estrogens. Estrogens act through different types of receptors to introduce signals to the target cell by affecting many estrogen response elements.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!